AZACITIDINE AQVIDA
25MG/ML INJ PLV SUS 1X100MG
| SÚKL code | 0242739 |
|---|---|
| Name of the product | AZACITIDINE AQVIDA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | AZACITIDINE AQVIDA |
| Supplement | 25MG/ML INJ PLV SUS 1X100MG |
| Strenght | 25MG/ML |
| Pharmaceutical form | Powder for suspension for injection |
| Package | 1X100MG |
| Route | Subcutaneous use |
| Language of the pack | Czech |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | AZACITIDINE (AZACITIDINUM) |
| ATC group | L01BC07 |
| ATC group name | AZACITIDIN |
Marketing authorisation information
| Registration Number | 44/ 120/19-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 12. 2021 |
| MA Holder | AqVida GmbH, Hamburg |
| MA Holder country | NĚMECKO |
| Actual MA holder | EVER-Valinject GmbH, Unterach am Attersee |
| Actual MA holder country | RAKOUSKO |
cz